Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2007
11/01/2007US20070254869 modulators of Cholesterol ester transfer protein activity, such as 5-[Acetyl-(3,5-bis-trifluoromethyl-benzyl)-amino]-7-trifluoromethyl-2,3,4,5-tetrahydro-benzo[b]azepine-1-carboxylic acid isopropyl ester, for treating or preventing cardiovascular disorders
11/01/2007US20070254867 Heterocyclic Kinase Inhibitors
11/01/2007US20070254298 Atropisomers of asymmetric xanthene fluorescent dyes and method of dna sequencing and fragment analysis
11/01/2007CA2650186A1 Process for preparing disulphides and thiosulphinates and compounds prepared
11/01/2007CA2649924A1 Inhibitors of c-fms kinase
11/01/2007CA2649739A1 Inhibitors of c-fms kinase
11/01/2007CA2649636A1 Diazepan derivatives modulators of chemokine receptors
11/01/2007CA2649512A1 C-fms kinase inhibitors
11/01/2007CA2648809A1 Indazole compounds and methods for inhibition of cdc7
11/01/2007CA2648612A1 Benzodioxane and benzodioxolane derivatives and uses thereof
11/01/2007CA2646678A1 Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/01/2007CA2646652A1 Substituted pyrazinone derivatives for use as a medicine
11/01/2007CA2646638A1 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors
11/01/2007CA2642835A1 Salt of sulfinylbenzimidazole compound, and crystal and amorphous form thereof
10/2007
10/31/2007EP1849782A1 Quinolinone derivatives as tyrosine kinase inhibitors
10/31/2007EP1849773A1 Pyridyl non-aromatic nitrogenated heterocyclic-1-carboxylate ester derivative
10/31/2007EP1848705A2 Exo- and diastereo- selective syntheses of himbacine analogs
10/31/2007EP1848698A2 Quinoxaline derivatives as antitumor agents
10/31/2007EP1848696A1 Imidazole and benzimidazole derivates useful as histamine h3 antagonists
10/31/2007EP1848694A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
10/31/2007EP1848692A1 AZOLYLACYLGUANIDINES AS ß-SECRETASE INHIBITORS
10/31/2007EP1848435A2 Compounds for inflammation and immune-related uses
10/31/2007EP1848275A1 Kappa opioid receptor ligands
10/31/2007EP1513821B1 Protein kinase inhibitors
10/31/2007EP1470143B1 Compounds that inhibit factor xa activity
10/31/2007EP1318980B1 Hydroxamate derivatives useful as deacetylase inhibitors
10/31/2007EP1242426B1 Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors
10/31/2007EP1153013B1 5-ht1f agonists
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007CN101065374A Substituted dipiperidine ccr2 antagonists
10/31/2007CN101065364A Novel pyrimidine derivatives and their use as PPAR-alpha modulators
10/31/2007CN101065363A Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
10/31/2007CN101065355A N- [ (3s)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors
10/31/2007CN100345844C Quinazoline derivatives for the treatment of tumours
10/31/2007CN100345841C Preparation for the production of 1,2,4-triazolymethyl-oxiranes
10/31/2007CN100345840C Stable hydrate of a muscarinic receptor antagonist
10/31/2007CN100345833C Modulators of dopamine neurotransmission
10/31/2007CN100345829C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/31/2007CN100345552C Enantiomerically pure beta-d-dioxolane nucleosides with selective anti-hepatitus b virus activity
10/30/2007US7288676 Arylphenyl-substituted cyclic ketoenols
10/30/2007US7288657 Biphenyl compounds useful as muscarinic receptor antagonists
10/30/2007US7288655 α v integrin receptor antagonists
10/30/2007US7288652 Method for preparing oltipraz
10/30/2007US7288545 e.g., 3-[(5-benzyloxypyridin-2-yl)methylidene]-6-phenylmethylidene piperazine-2,5-dione; treating an angiogenesis-related disease.
10/30/2007US7288543 Opioid receptor antagonists
10/30/2007US7288537 Azetidine derivatives as CCR-3 receptor antagonists
10/30/2007CA2416212C Indole derivatives useful for the treatment of cns disorders
10/30/2007CA2239227C Nitrogen-containing heterocyclic compounds
10/30/2007CA2179650C Bisindolemaleimides and their use as protein kinase c inhibitors
10/25/2007WO2007120824A2 Processes for the synthesis of azetidinone
10/25/2007WO2007120729A2 Pyridyl amide t-type calcium channel antagonists
10/25/2007WO2007120364A2 Metabolites of wortmannin analogs and methods of using the same
10/25/2007WO2007120101A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands
10/25/2007WO2007119889A1 Novel piperazine compound, and use thereof as hcv polymerase inhibitor
10/25/2007WO2007119816A1 Organic electroluminescence element material, organic electroluminescence element, display device and lighting apparatus
10/25/2007WO2007118903A1 Trisubstituted 1,2,4-triazoles
10/25/2007WO2007118852A1 Aryl and heteroaryl sulphonamides as growth hormone secretagogue receptor agonists
10/25/2007WO2007118589A1 Substituted diamino-1,3,5,-triazines, methods for the production thereof, and use thereof as herbicides and plant growth regulators
10/25/2007WO2007118314A1 1,5 and 3,6- substituted indole compounds having nos inhibitory activity
10/25/2007WO2007077508A3 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
10/25/2007WO2007076158A8 Processes for preparing darifenacin hydrobromide
10/25/2007US20070249840 Process for the preparation of bis-benzazolyl compounds
10/25/2007US20070249708 C7 ester and c10 hydroxy substituted taxanes
10/25/2007US20070249707 Taxanes having c7 hydroxy and c10 heterosubstituted acetate substituents
10/25/2007US20070249705 N-(1-(2,3-Dihydro-1H-Inden-5Yl)-2-Oxo-3-Pyrrolidinyl)-Sulfonamide Derivatives for Use as Factor Xa Inhibitors
10/25/2007US20070249701 Cyclic amine CCR5 receptor antagonists
10/25/2007US20070249698 Diarylimidazoles, substituted with another aromatic ring and one or more carboxylic acids, esters or amides, e.g., 3-[5-Benzo[1,3]dioxol-5-yl-4-(2,5-dichloro-phenyl)-1H-imidazol-2-yl]-2-(3-chloro-phenyl)-acrylic acid; treatment of conditions such as pain, drug dependence, and psychological disorders
10/25/2007US20070249669 Crystalline 2-amino-3-cyanoquinoline derivatives, process of their preparation and pharmaceutical compositions containing them
10/25/2007US20070249665 1-aryl-4-substituted isoquinolines
10/25/2007US20070249645 Such as N-(3-Benzyloxy-phenyl)-N-(4-thiazol-2-yl-pyrimidin-2-yl)-amine; allergic diseases, cancer, neurodegenerative and proliferative disorders, diabetes; inhibitors of GSK-3, Aurora2, and Syk protein kinases
10/25/2007US20070249644 Compounds and methods for the treatment of asthma
10/25/2007US20070249618 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression
10/25/2007US20070249601 Compounds and therapeutical use thereof
10/25/2007US20070249600 Chemical compounds
10/25/2007US20070249591 Biaryl Amino Acids and Their Use in Dna Binding Oligomers
10/25/2007US20070249578 New amidino derivatives and their use as thrombin inhibitors
10/25/2007US20070247585 Hexahydrodibenzofuran derivatives
10/25/2007US20070247063 Light-Emitting Device Material and Light-Emitting Device
10/25/2007DE102006018828A1 Alkoxyalkyl-substituierte cyclische Ketoenole Alkoxyalkyl-substituted cyclic ketoenols
10/25/2007DE102006016884A1 Substituierte Diamino-1,3,5-triazine, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren Substituted diamino-1,3,5-triazines, to processes for their preparation and their use as herbicides and plant growth regulators
10/25/2007DE102004002884B4 Aspernigrin B und Aspernigrin-B-Derivate, sie enthaltende pharmazeutische Zusammensetzungen und deren Verwendung Aspernigrin B-B and Aspernigrin derivatives, pharmaceutical compositions containing them and their use
10/25/2007CA2650404A1 Fused ring thrombin receptor antagonists
10/25/2007CA2649287A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands
10/25/2007CA2645961A1 Aminomethyl pyridine derivatives, method for preparing same and therapeutic use thereof
10/25/2007CA2643822A1 1,5 and 3,6- substituted indole compounds having nos inhibitory activity
10/25/2007CA2636040A1 Metabolites of wortmannin analogs and methods of using the same
10/24/2007EP1847540A1 Nouveaux dérivés d'épothilone, leur procédé de production et leur utilisation pharmaceutique
10/24/2007EP1847532A1 Igf-1r inhibitor
10/24/2007EP1847531A1 Pyrazole compound
10/24/2007EP1846397A1 Novel heterocyclic benzoy[c]chromene derivatives useful as modulators of the estrogen receptors
10/24/2007EP1846394A1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors
10/24/2007EP1846387A2 Bis-(coumarin) compounds with anti-inflammatory activity
10/24/2007EP1846385A2 An exo-selective synthesis of himbacine analogs
10/24/2007EP1846375A1 2-amino-1-phenylethylcarboxamide derivatives
10/24/2007EP1846372A2 Compounds for inflammation and immune-related uses
10/24/2007EP1218348B1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/24/2007CN101061110A Novel insecticides
10/24/2007CN101061098A Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
10/24/2007CN101061097A Novel gamma secretase inhibitors
10/24/2007CN101061096A Cycloalkyl keto piperidine tachykinin receptor antagonists
1 ... 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 ... 694